In this issue of the Journal, Falchook and colleagues describe patterns of end-of-life cancer care observed among commercially insured adult patients younger than age 65 years (1). Their analysis focuses on five National Quality Forum–endorsed measures that assess health care utilization among cancer patients at the end of life, including use of the emergency department (ED), intensive care unit (ICU), chemotherapy, and hospice. Derived in large part from work by Craig Earle and colleagues (2,3), many of the prior analyses using these and related measures have focused on the Medicare population. This report by Falchook and colleagues is among the first to report comprehensive results of end-of-life cancer care quality in a nationally representative, commercially insured patient cohort.

中文翻译：

---

社论：关于生命终结性癌症护理的质量和质量衡量

在这一期的《华尔街日报》上，Falchook及其同事描述了在65岁以下商业保险的成年患者中观察到的临终癌症护理模式（1）。他们的分析着重于五项全国质量论坛认可的评估寿命结束后癌症患者中医疗保健利用率的措施，包括急诊室（ED），重症监护病房（ICU），化学疗法和临终关怀的使用。很大程度上源自Craig Earle及其同事（2,3）的工作，使用这些方法和相关措施进行的许多先前分析都集中在Medicare人群上。Falchook及其同事的这份报告是第一个报告在具有全国代表性的商业保险患者队列中生命周期癌症护理质量综合结果的报告。